Global Technologies announces strategic pivot, new health, wellness agreements

Global Technologies (GTLL) announced corporate developments and commercial milestones signaling a bold pivot in strategy and leadership. Over the past 90 days, GTLL has responded proactively to external FDA regulatory shifts that disrupted several industry sectors, including GLP-1 compounding and semaglutide supply. These changes catalyzed GTLL’s sharpened focus on the digital health and wellness market, prompting operational streamlining and a commitment to scalable, revenue-focused platforms-particularly through its newly launched subsidiary, Primecare Supply. As disclosed in its May 30 Form 8-K filing, GTLL formally launched Primecare Supply and executed two transformative commercial agreements: On May 19, Primecare entered into a Revenue Share Agreement with a licensed pharmaceutical supplier. Under this structure, Primecare retains 75% of gross margin revenue above the supplier’s floor price while supporting FDA-compliant sales and post-sale obligations to its network of wellness providers. On May 28, Primecare signed a Master Licensing Agreement with a specialized AI technology partner, gaining access to tools for digital ordering, compliance automation, CRM management, and real-time operational analytics. The platform fee is 2.5% of processed transactions, with a 24-month licensing term.